Quantcast
Last updated on April 17, 2014 at 15:50 EDT

Latest Oncology Stories

2014-03-26 04:20:54

First System to Prevent Syringe Plunger Contamination Demonstrated at Barcelona, New Orleans, and Montreal Conferences BARCELONA, Spain, March 26, 2014 /PRNewswire/ -- Equashield (http://www.equashield.com [http://../ari/AppData/Local/Microsoft/Windows/Temporary InternetFiles/Content.Outlook/ZS150YTY/www.equashield.com ] ), the leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs, today announced its participation in three upcoming...

2014-03-25 23:28:12

GIA announces the release of a comprehensive global report on Circulating Tumor Cells and Cancer Stem Cells Technologies markets. Global market for Circulating Tumor Cells (CTC) Diagnostics is forecast to reach US$10 billion by 2020, driven by rising incidence of cancer, growing demand for effective diagnosis & treatment, and breakthrough research developments in understanding disease pathways. San Jose, California (PRWEB) March 25, 2014 Follow us on LinkedIn – High prevalence of...

2014-03-25 08:29:51

Inspired to save the lives of Coachella Valley cancer patients, BIGHORN Behind a Miracle (BAM) reached an exciting milestone of raising $1 million at their kick-off party, A Night of Miracles, for BIGHORN BAM Week that also includes a Caddy Auction and Golf Tournament. PALM DESERT, Calif., March 25, 2014 /PRNewswire/ -- BIGHORN BAM Founder Selby Dunham took her breast cancer survivor story and decided to give back to the hospital and community she loves so much. In the past 7...

2014-03-25 08:27:28

- Livenation.com and Ticketmaster.com Give Fans Opportunity to Help Fight Cancer through April 13, 2014 - LOS ANGELES, March 25, 2014 /PRNewswire/ -- Live Nation Entertainment (NYSE: LYV) and the American Cancer Society announced today a collaboration to raise awareness of cancer issues and critically needed funds to help finish the fight. http://photos.prnewswire.com/prnvar/20140325/LA85683LOGO Fans of concerts, sports, theater and family events can make a donation to help fight...

2014-03-24 23:27:51

Lead Candidate Provides Targeted and Personalized Medicine Approach to Lung Cancer Somerville, MA (PRWEB) March 24, 2014 ANDARIX Pharmaceuticals, a leader in the discovery and development of targeted peptide therapy for lung and neuroendocrine cancer announced today that P2045, the Company's lead candidate for targeted peptide therapy, has been granted Orphan Drug Designation by the U.S. Food & Drug Administration (FDA) for the treatment of small cell lung cancer (SCLC). Orphan...

2014-03-24 23:24:12

Japanese researchers say the drug Alimta (pemetrexed) in combination with cisplatin should remain the top first-line treatment for malignant pleural mesothelioma. Raleigh, NC (PRWEB) March 24, 2014 Japanese researchers say the drug Alimta (pemetrexed) in combination with cisplatin should remain the top first-line treatment for malignant pleural mesothelioma. Their findings have just been posted by Surviving Mesothelioma at...

2014-03-24 23:23:11

The Foundation for Women’s Cancer and the Claudia Cohen Research Foundation announce today that Dr. Andrew Berchuck has been selected as the 2014 recipient of the Foundation for Women’s Cancer/Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Researcher. The $50,000 prize is being presented at the Society of Gynecologic Oncology 45th Annual Meeting on Women's Cancer in Tampa. Tampa, FL (PRWEB) March 24, 2014 The Foundation for Women’s Cancer and the Claudia...

2014-03-24 16:24:20

Asbestos Disease Awareness Organization Celebrates 10 Years with 10th Annual International Asbestos Awareness Conference ALTON, Ill., March 24, 2014 /PRNewswire/ -- The Simmons Law Firm, a nationwide leader in mesothelioma and asbestos litigation, has renewed its commitment to support asbestos awareness in the United States and beyond as a Platinum Sponsor of the "Where Knowledge and Action Unite" 10(th) Annual International Asbestos Awareness Conference. (Photo:...

2014-03-24 12:30:19

Largest Study of Its Kind Shows Minimally Invasive Treatment May Slow Disease Progression in Liver While Maintaining Quality of Life SAN DIEGO, March 24, 2014 /PRNewswire-USNewswire/ -- A minimally invasive treatment that delivers cancer-killing radiation directly to tumors shows promise in treating breast cancer that has spread to the liver when no other treatment options remain, according to research being presented at the Society of Interventional Radiology's 39th Annual...

2014-03-24 08:28:31

PRINCETON, N.J., March 24, 2014 /PRNewswire/ -- Sirtex Medical Limited (ASX: SRX) and Guerbet S.A. (GBT.PA) are pleased to announce today that the two companies are entering into a collaboration to advance research in primary and secondary metastatic liver cancer. The objective of the collaboration is to evaluate the unmet clinical need in patients with hepatocellular carcinoma, metastatic colorectal cancer, neuroendocrine tumors, and a range of other secondary liver cancers*....